Abstract: The present invention relates to a Streptococcus pneumoniae antiserum without cross-reactivity and method for producing the same, more specifically, it relates to a method for producing a S. pneumoniae antiserum comprising the step of removing cross-reactivity using S. pneumoniae and a S. pneumoniae antiserum prepared by the method. The Streptococcus pneumoniae antiserum prepared according to the method of the present invention has very high specificity for a particular serotype, since the cross-reactivity with S. pneumoniae of serotypes expressing capsular polysaccharides of similar structure is removed. Therefore, it can be very useful in the related art that requires accurate quantification of S. pneumoniae capsular polysaccharide.

Abstract: A method and apparatus for coating an electrode is disclosed herein. In some embodiments, an apparatus for coating an electrode slurry includes a coating die configured to coat an electrode slurry on one surface of a current collector, a thickness measuring sensor spaced apart from the current collector by a predetermined interval and configured to measure a thickness of the coated electrode slurry in real time after coating by the coating die; and a controller which controls a coated amount of the electrode slurry in real time according to the measured thickness.

Abstract: The present invention relates to a method for stably maintaining a poly(A) tail.

Abstract: The present application relates to a compound represented by Chemical Formula 1, an organic optoelectronic diode and a display device.

Abstract: The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae polysaccharide-protein conjugate, comprising a capsular polysaccharide derived from one or more selected from the group consisting of serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F, derived from Streptococcus pneumoniae; and one or 2 or more of carrier proteins conjugated to the respective capsular polysaccharide, and method of preparation thereof. Through one example of the present invention, an immunogenic composition for preventing or treating pneumococcal infection can be provided.

Abstract: The present disclosure relates to an organic light emitting diode and an organic light emitting device including the same. The organic light emitting diode includes a first electrode; a second electrode facing the first electrode; and a first blue emitting material layer including a first compound and a second compound and positioned between the first and second electrodes, wherein the first compound is represented by Formula 1, and the second compound is represented by Formula 3. According to an aspect of the present disclosure, it is allowed to provide an OLED and an organic light emitting device having high emitting efficiency and/or improved lifespan.

Abstract: The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae polysaccharide-protein conjugate, comprising a capsular polysaccharide derived from one or more selected from the group consisting of serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F, derived from Streptococcus pneumoniae; and one or 2 or more of carrier proteins conjugated to the respective capsular polysaccharide, and method of preparation thereof. Through one example of the present invention, an immunogenic composition for preventing or treating pneumococcal infection can be provided.

Abstract: A method and apparatus for coating an electrode is disclosed herein. In some embodiments, an apparatus for coating an electrode slurry includes a coating die configured to coat an electrode slurry on one surface of a current collector, a thickness measuring sensor spaced apart from the current collector by a predetermined interval and configured to measure a thickness of the coated electrode slurry in real time after coating by the coating die; and a controller which controls a coated amount of the electrode slurry in real time according to the measured thickness.

Abstract: The present invention relates to a Streptococcus pneumoniae antiserum without cross-reactivity and method for producing the same, more specifically, it relates to a method for producing a S. pneumoniae antiserum comprising the step of removing cross-reactivity using S. pneumoniae and a S. pneumoniae antiserum prepared by the method. The Streptococcus pneumoniae antiserum prepared according to the method of the present invention has very high specificity for a particular serotype, since the cross-reactivity with S. pneumoniae of serotypes expressing capsular polysaccharides of similar structure is removed. Therefore, it can be very useful in the related art that requires accurate quantification of S. pneumoniae capsular polysaccharide.

Abstract: The present application relates to a compound represented by Chemical Formula 1, an organic optoelectronic diode and a display device.

Abstract: The present disclosure relates to an organic compound including an electron acceptor moiety of a hetero aromatic ring having at least one nitrogen as a nuclear atom and an electron donor moiety of a fused aromatic or a fused hetero aromatic ring linked to the electron acceptor moiety directly or via a linker moiety, and an organic light emitting diode (OLED) and an organic light emitting device including the organic compound. The organic compound includes both the electron acceptor and donor moieties, thus charges can be transported easily within the molecule. The OLED and the organic light emitting device including the organic compound, which may comprise at least one substituent having strong electron withdrawing property at specific position, in an emissive layer can implement excellent luminous efficiency and luminous lifespan.

Abstract: The present disclosure relates to an organic compound in which an electron acceptor moiety and an electron donor moiety of a fused aromatic ring or a hetero aromatic ring are directly linked or through an linker moiety and they are connected via carbon-carbon bond, and an organic light emitting diode (OLED) and an organic light emitting device including the organic compound. The organic compound includes both the electron acceptor and donor moieties that are linked directly or through a linker moiety via a carbon-carbon bond having strong bond energy within its molecule, thus charges can be transported easily within the molecule. The OLED and the organic light emitting device including the organic compound in an emissive layer can implement excellent luminous efficiency and luminous lifespan.

Abstract: The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae polysaccharide-protein conjugate, comprising a capsular polysaccharide derived from one or more selected from the group consisting of serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F, derived from Streptococcus pneumoniae; and one or 2 or more of carrier proteins conjugated to the respective capsular polysaccharide, and method of preparation thereof. Through one example of the present invention, an immunogenic composition for preventing or treating pneumococcal infection can be provided.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 2 or 9N. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: The present invention provides an improved method of producing a capsular polysaccharide having a pneumococcal serotype. The method according to the present invention includes a step of additionally culturing bacterial cells producing a pneumococcal serotype without pH adjustment, thereby removing a protein precipitation process by acidification with a pH adjuster.

Abstract: Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 2 or 9N. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 22F or 33F. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.